Treatment strategies for oropharyngeal candidiasis

Author： Laudenbach Joel M   Epstein Joel B  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.9, 2009-06, pp. : 1413-1421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Posaconazole vs fluconazole in oropharyngeal candidiasis

By  

Inpharma, Vol. 1, Iss. 1535, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Fluconazole superior to itraconazole in oropharyngeal candidiasis

By  

Inpharma, Vol. 1, Iss. 1446, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

BioAlliance Pharma has launched a miconazole buccal tablet [Loramyc] in France for the treatment of oropharyngeal candidiasis

By  

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Weekly fluconazole prevents oropharyngeal candidiasis relapses

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Neonatal candidiasis: prophylaxis and treatment

By Tiffany Kenneth F   Smith Phillip B   Benjamin Jr Daniel K  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1647-1655

Informa Healthcare

Access to resources Recommend Favorite